- Home
- Research
- Endocannabinoid
- Effects of an internet-based combined exercise and cognitive-behavioral therapy intervention on endocannabinoid system biomarkers and physical fitness in adults with mild-to-moderate depression: a SONRIE randomized controlled trial.
Exercise plus online therapy improved fitness, not cannabinoid markers
Effects of an internet-based combined exercise and cognitive-behavioral therapy intervention on endocannabinoid system biomarkers and physical fitness in adults with mild-to-moderate depression: a SONRIE randomized controlled trial.
AI Summary
This randomized controlled trial asked whether a 12-week program combining physical exercise and internet-based cognitive-behavioral therapy (iCBT) changed endocannabinoid system biomarkers or fitness in 80 adults with mild-to-moderate depression. Participants were assigned to the combined intervention or a control group, with assessments at the start, after the program, and at follow-up. The primary reported finding was that the intervention improved cardiorespiratory fitness: the between-group difference in the 6-minute walking test was +81.6 m at 12 weeks, and the abstract says this exceeded the established threshold for a clinically important change.
The intervention did not produce a significant group-specific change in any measured plasma endocannabinoid system biomarker, including 2-AG and AEA; both groups showed comparable decreases in some biomarkers. Exploratory muscular-fitness outcomes were not statistically significant. This is an abstract-based summary: the findings concern a combined exercise-and-therapy program, not cannabis use or cannabinoid treatment, and the abstract cannot establish why fitness improved or whether the biomarker results generalize beyond this study population.
๐ก Key Findings
๐
Original Abstract
Related Research
Similar Studies
More Endocannabinoid research papers you might find interesting.
Review links cannabis to possible heart attack mechanisms, not proven risk
Visceral fat endocannabinoid production rose with diabetes, not obesity alone
Targeted CB2 drug delivery reduced mouse plaque deposits, with sex differences
Explore More Research
Stay informed about the latest cannabis science.